Medium materiality6/10
Ionis Pharmaceuticals (IONS) PT Lowered to $80 at Guggenheim
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim lowers IONS target to $80; current price is $51.44.
- Target $80; price $51.44
Key facts
- 01
Target: $80
- 02
Posted price: $51.44
- 03
Analyst firm: Guggenheim
- 04
Analyst: Debjit Chattopadhyay
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.